123 related articles for article (PubMed ID: 33127550)
1. Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil.
Abe Y; Shibata H; Oyama K; Ueda T
Int J Biol Macromol; 2021 Jan; 166():342-351. PubMed ID: 33127550
[TBL] [Abstract][Full Text] [Related]
2. Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of Vλ6 proteins associated with AL amyloidosis.
Takahashi D; Matsunaga E; Yamashita T; Caaveiro JMM; Abe Y; Ueda T
Biochem Biophys Res Commun; 2022 Mar; 596():22-28. PubMed ID: 35108650
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
[TBL] [Abstract][Full Text] [Related]
4. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
Hernández-Santoyo A; del Pozo Yauner L; Fuentes-Silva D; Ortiz E; Rudiño-Piñera E; Sánchez-López R; Horjales E; Becerril B; Rodríguez-Romero A
J Mol Biol; 2010 Feb; 396(2):280-92. PubMed ID: 19941869
[TBL] [Abstract][Full Text] [Related]
5. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate.
Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.
Wall J; Schell M; Murphy C; Hrncic R; Stevens FJ; Solomon A
Biochemistry; 1999 Oct; 38(42):14101-8. PubMed ID: 10529258
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for retardation of amyloid fibril formation by sugars in Vλ6 protein.
Abe M; Abe Y; Ohkuri T; Mishima T; Monji A; Kanba S; Ueda T
Protein Sci; 2013 Apr; 22(4):467-74. PubMed ID: 23389799
[TBL] [Abstract][Full Text] [Related]
9. Formation of amyloid fibers by monomeric light chain variable domains.
Brumshtein B; Esswein SR; Landau M; Ryan CM; Whitelegge JP; Phillips ML; Cascio D; Sawaya MR; Eisenberg DS
J Biol Chem; 2014 Oct; 289(40):27513-25. PubMed ID: 25138218
[TBL] [Abstract][Full Text] [Related]
10. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
[TBL] [Abstract][Full Text] [Related]
11. Mutational and genetic determinants of λ6 light chain amyloidogenesis.
González-Andrade M; Becerril-Luján B; Sánchez-López R; Ceceña-Álvarez H; Pérez-Carreón JI; Ortiz E; Fernández-Velasco DA; del Pozo-Yauner L
FEBS J; 2013 Dec; 280(23):6173-83. PubMed ID: 24107228
[TBL] [Abstract][Full Text] [Related]
12. Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast.
He J; Song Y; Ueyama N; Saito A; Azakami H; Kato A
Protein Sci; 2006 Feb; 15(2):213-22. PubMed ID: 16434741
[TBL] [Abstract][Full Text] [Related]
13. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains.
Kim YS; Cape SP; Chi E; Raffen R; Wilkins-Stevens P; Stevens FJ; Manning MC; Randolph TW; Solomon A; Carpenter JF
J Biol Chem; 2001 Jan; 276(2):1626-33. PubMed ID: 11050093
[TBL] [Abstract][Full Text] [Related]
14. Probing the role of λ6 immunoglobulin light chain dimerization in amyloid formation.
Wolwertz ML; Nguyen PT; Quittot N; Bourgault S
Biochim Biophys Acta; 2016 Apr; 1864(4):409-18. PubMed ID: 26802902
[TBL] [Abstract][Full Text] [Related]
15. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
[TBL] [Abstract][Full Text] [Related]
16. Effects of His mutations on the fibrillation of amyloidogenic Vlambda6 protein Wil under acidic and physiological conditions.
Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
Biochem Biophys Res Commun; 2010 Jan; 391(1):615-20. PubMed ID: 19932684
[TBL] [Abstract][Full Text] [Related]
17. MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
Hora M; Sarkar R; Morris V; Xue K; Prade E; Harding E; Buchner J; Reif B
PLoS One; 2017; 12(7):e0181799. PubMed ID: 28746363
[TBL] [Abstract][Full Text] [Related]
18. Effects of oxidative post-translational modifications on structural stability and self-assembly of λ6 immunoglobulin light chain.
Zottig X; Laporte Wolwertz M; Golizeh M; Ohlund L; Sleno L; Bourgault S
Biophys Chem; 2016 Dec; 219():59-68. PubMed ID: 27744229
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin light chain amyloid aggregation.
Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
[TBL] [Abstract][Full Text] [Related]
20. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
